Combine and Conquer: A Treatment Strategy to Combat Drug-Use Associated Infections
Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.
Sandra Springer, MD, and Laura Marks, MD, PhD, highlight the need for a combined treatment approach for patients with drug-use associated infections.
Radmila Lyubarova, MD, and Michael G. Nanna, MD, discuss the lack of awareness regarding risk for ASCVD in women and disparities in treatment that they face.
The understudied relationship between muscle mass and nonalcoholic fatty liver disease is assessed, including expert opinions the topic.
In a Q&A, Asher Schranz, MD, MPH, discusses the importance of physician collaboration in the treatment of patients with drug use-associated infective endocarditis.
Compared with nonpharmacologic approaches, research consistently supports the benefits of medication for opioid use disorder, including fewer deaths, higher rates of sustained recovery, and greater cost-effectiveness.
To discuss the potential factors driving the increasing alcohol use among women as well as potential solutions, we interviewed David Streem, MD, and Leena P. Mittal, MD, FACLP.
A significant number of cases of post-COVID-19 myocarditis have been reported.
Cardiologists around the world report experiencing harassment and discrimination in the workplace.
Higher rates of smoking, lower rates of lung cancer screening, and more diagnoses of asthma and COPD have been seen in transgender vs cisgender individuals.
With many Americans awaiting to be vaccinated, while others indicating they are unlikely to get the jab, we spoke with 2 experts for their perspectives regarding this controversial topic.